Ty Louis Campbell was just two years and ten months old in August 2010, when a mass was found at the base of his skull, pressing against his brainstem. Soon after, he was diagnosed with a rhabdoid tumor, which is a very rare and aggressive cancer specific to pediatrics. People started calling him "SuperTy" because he loved superheroes, and because he showed such strength throughout his treatment. He passed away at home in his parents’ arms on October 17, 2012.
The Ty Louis Campbell (TLC) Foundation was created in his honor to raise awareness for pediatric cancer through the story of his courageous battle, and to help fund the progress that is being made in developing more effective, less harmful treatment for a range of high-risk pediatric cancers. At TLC, we support our mission with a three-tiered approach focused on fundraising, volunteerism and charitable merchandising.
(1) The Ty Louis Campbell Foundation is the core of our organization. It is the beneficiary of all fundraising, and the sole source of decision-making around all of our childhood cancer research investments. (2) The PRET*TY Store is a growing brand of predominantly bracelets and other assorted charitable merchandise that directly benefit the foundation. (3) The Muddy Puddles Project celebrates kids being kids in honor of those who can’t. This national public awareness and participation campaign was inspired by Ty, who dreamed of jumping in muddy puddles when he was cured of cancer. The core of the project involves getting communities involved in hosting activities that get children outside; letting them dance in the rain, jump in the mud, play in the sand and run among the wildflowers.
The Ty Louis Campbell Foundation is a nonprofit organization (EIN: 45-1858390) that funds innovative research and clinical trials specifically geared toward the treatment of the most aggressive childhood cancers (including brain and spinal cord tumors). Our organization seeks less toxic, more effective treatments that are specifically designed for children fighting cancer. Our ultimate mission is to help fund the intelligence and technology that will improve long-term survival rates for all children diagnosed with cancer.